.png)

A right of first refusal, or ROFR, gives the company and then existing investors the right to buy shares before an outside buyer can. In a venture-backed company, that is standard. It exists in almost every Series A financing and it is included in the NVCA's April 2026 model Right of First Refusal and Co-Sale Agreement as a core investor protection.
The problem is not the clause itself. The problem is what happens when the notice periods are too long, the waiver mechanics are vague, the exercise rights cascade through multiple investor classes, and the ROFR is not coordinated with co-sale and drag-along provisions. When those pieces are misaligned, a standard transfer restriction becomes a procedural choke point. A secondary sale stalls. A Series B diligence team flags the cap table. A legacy holder gains negotiating leverage they were never supposed to have.
This is part of a broader set of cap table issues that can block institutional financing. If you have not reviewed your full cap table structure, the guide to what cap table problems kill a Series B before the lead reads your deck is the right place to start.
Key takeaways:
In a clean structure, the process is sequential and time-limited. A selling shareholder, typically a founder or key holder, delivers a proposed transfer notice to the company. That notice includes the buyer's identity, the price, the number of shares, and the payment terms. The company then has a defined window to elect to purchase all or part of those shares at the same price. If the company declines or does not respond within the window, investors get a secondary refusal right to purchase whatever shares remain. Only after all those elections lapse or are waived can the outside buyer proceed. If you are still working through how your company's valuation affects these mechanics, the guide to how to value a startup and what investors look for at each stage is useful context before reviewing your ROFR terms.
Under the NVCA April 2026 model, the timing stack looks like this:
That sequence is manageable when the notice is complete, the windows are short, and the waiver authority is clear. The total minimum timeline from notice to closing can run 40 to 70 days even when everything works perfectly.
Where it breaks down is when any step in that chain is ambiguous, contested, or silent on what happens if a party does not respond. That silence is where blocking leverage enters.
Most ROFR problems do not come from bad intent. They come from clauses that were drafted at Series A and never revisited. By the time a secondary sale or Series B process begins, the document has gaps that give legacy holders more procedural power than anyone intended.
The five most common drafting failures are:
"Broadly worded transfer or assignment language often fails to distinguish security interests from outright sales, inadvertently capturing standard debt financings and routine restructurings within the ROFR trigger." — Dechert LLP analysis of common ROFR drafting defects
Founders raising a Series A round should understand that these provisions will be inherited by every future transaction. The guide to how to raise capital for your Series A round covers the term sheet review process where these mechanics should be negotiated.
Here is what the friction looks like in a real transaction sequence. The steps below are not hypothetical edge cases. They are the normal result of a ROFR agreement with the drafting failures described above.
"The multi-step notice and exercise periods for key holder stock transfers can complicate cap table cleanups needed for Series B due diligence." — Triumph Law, Series B Financing Overview
If a Series B is running in parallel, the new lead investor's diligence team is watching all of this. Unresolved transfer restrictions and disputed notices signal that the cap table is not operationally clean. That is often enough to slow-walk a term sheet or require a formal cap table cleanup as a closing condition.
The process cost is real even when the deal eventually closes. Every disputed notice, consent chase, and oversubscription round adds legal fees, management time, and timeline risk. When a Series B is in progress at the same time, the damage compounds.
The four economic consequences that matter most:
Side letters that modify ROFR terms or create undisclosed transfer restrictions are a specific version of this problem. The article on side letters and side agreements in this series covers how those undisclosed commitments create their own diligence landmines at Series B.
Founders who have not yet mapped their full equity structure can start with the guide to how equity, debt, and SAFEs interact across your capital stack before opening any diligence process.
Review these items before you launch a secondary process or open a Series B data room. Each one addresses a specific failure mode from the sections above.
Vesting schedules and acceleration provisions interact with ROFR mechanics in secondary sales because unvested shares are typically subject to company repurchase rights that run alongside the ROFR process. The article on founder vesting cliffs and acceleration provisions in this series explains how those provisions affect transfer timing.
No. ROFR provisions in a standard NVCA agreement apply to transfers of existing shares by current holders, not to new share issuances. A Series B financing creates new preferred stock, which is governed by preemptive rights in the Investor Rights Agreement, not the ROFR and co-sale agreement. Founders sometimes confuse the two, but they are separate documents with separate mechanics.
This depends entirely on how the agreement is drafted. In most venture-backed companies, the board of directors has authority to waive the company's ROFR for a specific transaction. Some agreements require a supermajority of preferred stockholders. If the agreement is silent, the waiver authority is ambiguous and any exercise or non-exercise can be challenged. Check the specific language before assuming the board can act alone.
The exercise windows generally do not start running until a valid, complete notice is delivered. If a notice is missing required information, such as the buyer's identity, the price, or the payment terms, a rights holder can argue the clock never started. This is one of the most common sources of delay in secondary transactions and the most common basis for re-noticing a transfer.
Yes, and this is a serious risk. Side letters that grant an investor a broader right of first offer, a consent right over transfers, or a modified notice period can create obligations that conflict with the main ROFR agreement. If those side letters are not disclosed to a Series B lead during diligence, they become a closing problem. Every side letter should be reviewed against the ROFR and co-sale agreement before any liquidity event.
Under a market-standard structure based on the NVCA April 2026 model, the minimum timeline from notice to transfer closing is approximately 40 to 70 days when all parties respond promptly and no disputes arise. In practice, contested notices, extension requests, and oversubscription elections can push that timeline to 90 days or longer. Most secondary buyers factor this into their willingness to hold a price firm.
It can, depending on how the agreement defines a transfer. Broadly drafted agreements that include pledges, assignments, or security interests within the definition of a transfer can inadvertently trigger the ROFR process for a routine secured loan. Market-standard agreements include carve-outs for customary bank loans and pledges to financial institutions. If your agreement lacks those carve-outs, a secured lender may require a ROFR waiver before advancing funds.
Before opening diligence, confirm that every ROFR, co-sale, and drag-along agreement is current, that all notice windows and waiver triggers are clearly defined, that no side letters create undisclosed transfer restrictions, and that consent thresholds reflect the actual current cap table. Unresolved ROFR issues are a common Series B closing condition that adds weeks to the process and weakens the company's negotiating position on other terms.
Most founders don't lose the raise because of the pitch. They lose it because the structure was wrong before the first investor call. IRC Partners advises founders raising $5M to $250M of institutional capital. 7 strategic partners per quarter. Start here to schedule a call with our team.
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of 7
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.